Access Pro Medical

What Access Pro Medical does

Access Pro Medical is a U.S.-based medical device distribution company headquartered in Augusta, Georgia, founded in 2009. The company serves as the exclusive domestic distributor of MatriDerm, a single-use acellular dermal matrix composed of native bovine collagen types I, III, and V with added elastin. MatriDerm is used in soft tissue reconstruction applications including plastic reconstruction, burns, traumatic injury repair, chronic wound management, cancer excision reconstruction, flap donor sites, and mucosal defect repair, and is supported by clinical evidence spanning 5 randomized controlled trials and 12-year follow-up data.

The company's revenue model is hardware product sales to U.S. hospitals and healthcare providers via direct enterprise field sales, quote-based procurement contracts, and a digital marketing presence built around a dedicated product website (matridermusa.com) with persona-targeted content for physicians, hospital administrators, and sales professionals. Access Pro Medical competes in the wound care and dermal matrix segment with a clinically differentiated single-product offering, claiming materially lower infection rates (0-5%) versus the market-leading competitor (14-55%) and faster neovascularization (3-7 days).

The company operates with 51-100 employees and serves an exclusively domestic U.S. market. It does not develop AI/ML or software products, does not have disclosed funding, and has not announced acquisitions, mergers, or major leadership changes in the available data. The business model is therefore narrowly concentrated on the commercial success of a single distributed SKU whose manufacturing and intellectual property originate outside the company.

Name

Access Pro Medical

Legal name

Access Pro Medical

Website

https://accesspromedical.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Short description

Access Pro Medical is the exclusive U.S. distributor of MatriDerm, a single-use acellular dermal matrix for soft tissue reconstruction, sold to U.S. hospitals and surgeons via enterprise field sales.

Ownership category

akta.pro rank

Product category

Wound Care Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Medical Equipment and Supplies Manufacturing (33911)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Pharmaceutical & Medical Plastic Packaging Manufacturing (IMANAEAK)

akta.pro secondary industry

Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers) (HLAMAFAF)

Keywords

• Wound care supplies
• Dermal matrix products
• Medical device distribution
• Soft tissue reconstruction
• Burn care devices

Headquarters

HQ city

Augusta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Sale of single-use dermal matrix products (MatriDerm) to U.S. hospitals and healthcare providers through direct sales relationships and hospital contracts. Revenue is generated through product distribution as the exclusive U.S. distributor of MatriDerm.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Access Pro Medical is the exclusive U.S. distributor of MatriDerm, a single-use acellular dermal matrix medical device composed of native bovine collagen I, III and V with added elastin. The product is used by surgeons and hospitals for plastic reconstruction, burn treatment, traumatic injury repair, chronic wound management, cancer excision reconstruction, flap donor sites, and mucosal defects. Revenue is generated through direct sales to U.S. hospitals and healthcare providers under contract.

Product overview

Access Pro Medical serves as the exclusive U.S. distributor for MatriDerm®, a single-use acellular dermal matrix medical device. MatriDerm® is composed of native bovine collagen I, III and V with added elastin, making it unique among dermal matrices. The product is used across multiple clinical applications including plastic reconstruction, burns, traumatic injury, chronic wounds, cancer excision, flap donor sites, and mucosal defects. The company focuses on distributing this single medical device product, supported by clinical evidence including publications with 5 RCTs and 12-year follow-up data.

Differentiator

Problem solved

Functional benefit

Products and services

• MatriDerm MatriDerm is a single-use acellular dermal matrix composed of native bovine collagen I, III and V with added elastin, designed for wound management and soft tissue reconstruction. It is the only dermal matrix in its class containing added elastin and supports neovascularization in 3-7 days. Used by surgeons for plastic reconstruction, burns, traumatic injury, chronic wounds, cancer excision, flap donor sites, and mucosal defects.

Quantifiable outcome

• Neovascularization achieved in 3-7 days
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Mölnlycke Health Care: Mölnlycke is a European-based wound care major with Mepitel, Mepilex, and Avance products serving the same surgical and burn wound management use cases as MatriDerm. It competes as a portfolio incumbent in hospital wound care formularies.
• 3M Health Care (Solventum): 3M's health care business (now Solventum) includes a broad wound care and skin integrity portfolio, including advanced surgical dressings and skin closure products. It serves the same hospital surgical and wound care markets as Access Pro Medical, with significant installed-base advantage.
• Coloplast: Coloplast's Wound & Skin Care division offers Biatain and other advanced wound dressings and skin care products targeting chronic wounds and post-surgical care. It is a broader wound care incumbent whose offerings overlap with MatriDerm's clinical use cases, particularly in chronic wound management.
• ConvaTec: ConvaTec is a global wound care incumbent with a portfolio spanning advanced wound dressings, negative pressure wound therapy, and skin substitutes. While not a single-product competitor, it addresses the same wound management use cases as MatriDerm across hospitals and post-acute care settings.
• Smith & Nephew: Smith & Nephew is a global medical device incumbent with a significant Advanced Wound Management portfolio (including ACTICOAT, PICO, and skin substitute products). It competes with Access Pro Medical across multiple wound care and reconstruction indications, though as part of a much broader portfolio rather than a dermal-matrix specialist.

Direct peers

• MiMedx: MiMedx distributes EpiFix and AmnioFix dehydrated amniotic membrane allografts used for wound care and soft tissue applications. It is a direct competitor in the regenerative wound care space, targeting similar hospital outpatient and surgical accounts as Access Pro Medical.
• Integra LifeSciences: Integra LifeSciences is the direct competitor referenced in the data as the "market-leading competitor" with reported 14-55% infection rates. Its Integra Dermal Regeneration Template competes head-to-head with MatriDerm in burn and soft tissue reconstruction, making it the most directly comparable peer for Access Pro Medical's product positioning.
• LifeNet Health: LifeNet Health is a non-profit tissue bank that distributes dermal allografts and other regenerative tissue grafts for wound care and reconstructive surgery. It competes with MatriDerm in the same surgical reconstructive and burn care market with a comparable distribution model to hospitals.
• Organogenesis: Organogenesis manufactures and distributes Apligraf and other living cell-based skin substitutes and regenerative wound care products used for chronic wounds and burns. It competes in the same surgical wound management and soft tissue reconstruction category as MatriDerm, with overlapping customer call points at hospitals and wound care clinics.

Emerging players

• AlloSource: AlloSource is a non-profit allograft provider offering dermal matrices (AlloDerm RTM and other regenerative tissue products) for surgical reconstruction. It competes directly with MatriDerm in hospital-based soft tissue reconstruction procedures, particularly for plastic and reconstructive surgery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@accesspromedical6103
• Facebookfacebook.com/AccessProMedical
• LinkedInlinkedin.com/company/access-pro-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Access Pro Medical